CASPAR Criteria for Psoriatic Arthritis

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
caspar classification
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Does Not Meet CASPAR Criteria0–2
  • Meets CASPAR Criteria3–6
Direct Clinical Answer

The CASPAR Criteria for Psoriatic Arthritis calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include inflammatory articular disease. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Provides standardized classification criteria for identifying psoriatic arthritis (PsA) in patients with inflammatory arthritis. Requires presence of inflammatory articular disease plus ≥3 points from additional criteria.

Clinical Indication

The CASPAR Criteria for Psoriatic Arthritis is indicated for bedside clinical practice to support Provides standardized classification criteria for identifying psoriatic arthritis (PsA) in patients with inflammatory arthritis. Requires presence of inflammatory articular disease plus ≥3 points from additional criteria.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.

Limitations & Contraindications

Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.

Clinical Pearls & Action Plan

Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology. Guideline pearl: Sensitivity: 91%, Specificity: 98%.

Formula & Variables:

CASPAR Classification requires: 1) Inflammatory articular disease (mandatory) PLUS 2) ≥3 points from: Current psoriasis (2 pts), History of psoriasis (1 pt), Nail dystrophy (1 pt), RF negative (1 pt), Dactylitis (1 pt), Juxtaarticular new bone formation (1 pt)

Input Parameters

NameTypeRequiredDescription
inflammatory_articular_diseasestringYesPresence of inflammatory articular disease (joint, spine, or entheseal) - MANDATORY CRITERION
psoriasis_statusstringYesCurrent psoriasis status or history
nail_dystrophystringYesNail dystrophy: onycholysis, pitting, or hyperkeratosis on examination
rheumatoid_factorstringYesRheumatoid factor status (preferred: ELISA or nephelometry)
dactylitisstringYesDactylitis: current or historical swelling of entire digit
juxta_articular_new_bonestringYesJuxtaarticular new bone formation: ill-defined ossification near joint margins on X-ray

Score Interpretation & Guidance

RangeStageDescription
0–2Does Not Meet CASPAR CriteriaInsufficient criteria for psoriatic arthritis classification
3–6Meets CASPAR CriteriaMeets criteria for psoriatic arthritis classification

Evidence-Based References (EBM)

  • Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006 Aug;54(8):2665-73. doi: 10.1002/art.21972.DOI: 10.1002/art.21972
  • Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. J Rheumatol. 2008 Oct;35(10):2069-70.
  • Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii3-8. doi: 10.1136/ard.2004.032318.DOI: 10.1136/ard.2004.032318

Related calculators